2018 GAPNA Pharmacology Conference

204 - Hepatitis C - The Road to a Cure

Mar 17, 2018 11:25am ‐ Mar 17, 2018 12:55pm


Credits: None available.

Standard: $35.00
Members: $30.00

Description

Hepatitis C is a viral infection that affects 3-5 million Americans. It can be an insidious infection and often goes undetected. If left untreated, it can lead to devastating consequences, such as cirrhosis, liver cancer, and liver failure. However, once diagnosed, it can be cured!

Contact hours available until 3/17/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Conferences Committee Disclosures: There are no disclosures to declare.

Speakers Conflict of Interest Disclosure:
Michelle Baytarian discloses that she serves on the speakers’ bureaus for Gilead, Merck, and Abbvie.

Commercial Support and Sponsorship: No commercial support or sponsorship declared.

Accreditation Statement:
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

Learning Outcome:
After attending this session, the learner will be able to outline the currently available treatment modalities for hepatitis C.

Speaker(s):

Credits Available


Hepatitis C - The Road to a Cure

You must be logged in and own this session in order to post comments.